PACS Group adds former CMS deputy administrator to board

PACS Group Inc. (NYSE: PACS) announced the appointment of Patrick H. Conway, MD, MSc, to its board of directors. Conway currently serves as CEO of Optum, the health services division of UnitedHealth Group.

Conway previously held senior positions at the Centers for Medicare and Medicaid Services from 2011 to 2017, including deputy administrator for innovation and quality, director of the Center for Medicare and Medicaid Innovation, and chief medical officer. He also served as principal deputy administrator and acting administrator of CMS.

During his tenure at CMS, Conway led initiatives that increased Medicare payments in alternative payment models from virtually zero to more than 30 percent of all Medicare payments. He helped establish Accountable Care Organizations and the Medicare Shared Savings Program.

From 2017 to 2019, Conway served as president and CEO of Blue Cross and Blue Shield of North Carolina. He joined Optum in 2020 as CEO of Care Solutions before being elevated to CEO of Optum in May 2025.

Conway was elected to the National Academy of Medicine in 2014 and received the President's Senior Executive Distinguished Service Award. He earned his medical degree from Baylor College of Medicine and holds a Master of Science in Clinical Epidemiology from the University of Pennsylvania.

"Dr. Conway's career is extraordinary by any measure," said Jason Murray, chairman and CEO of PACS Group. "The depth and breadth of knowledge and perspective he brings to our Board is unlike anything the post-acute and skilled nursing sector has seen."

PACS operates more than 320 post-acute care facilities across 17 states, serving more than 31,700 patients daily. The company reported full-year 2025 revenue of $5.29 billion, representing 29.3 percent growth year-over-year.

Conway said post-acute care represents "one of the most important and underappreciated parts of the American healthcare system" and noted the increasing importance of skilled nursing providers as patient acuity shifts from acute to post-acute settings.

You May Also Be Interested In

• NNN REIT adds two directors amid board succession planning
• Ulta Beauty names PacSun CEO Brieane Olson to its board
• Standard Nuclear names former DOE nuclear policy chief to its board